Breast Cancers with HER2/CEP17 Ratio ≥2.0 and an Average HER2 Copy Number < 4.0 per Cell: Clinicopathologic Features and Alternative Chromosome 17 Probe Analysis of 102 Cases from a Single Institution Study

被引：0
|
作者：
Bai, Qianming [1 ]
Zhou, Shuling [1 ]
Zhu, Xiaoli
Zhou, Xiaoyan [1 ]
Yang, Wentao [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
111
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Breast Cancers with HER2/CEP17 Ratio ≥2.0 and an Average HER2 Copy Number < 4.0 per Cell: Clinicopathologic Features and Alternative Chromosome 17 Probe Analysis of 102 Cases from a Single Institution Study
    Bai, Qianming
    Zhou, Shuling
    Zhu, Xiaoli
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
  • [2] A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
    Zhou, Shuling
    Lv, Hong
    Li, Anqi
    Li, Ming
    Zhong, Siyuan
    Lu, Hongfen
    Zhou, Xiaoyan
    Bai, Qianming
    Yang, Wentao
    BMC CANCER, 2023, 23 (01)
  • [3] A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
    Shuling Zhou
    Hong Lv
    Anqi Li
    Ming Li
    Siyuan Zhong
    Hongfen Lu
    Xiaoyan Zhou
    Qianming Bai
    Wentao Yang
    BMC Cancer, 23
  • [4] A clinicopathological study of 30 breast cancer cases with a HER2/CEP17 ratio of ≥2.0 but an average HER2 copy number of <4.0 signals per cell
    Wang, Xiaoling
    Teng, Xiaodong
    Ding, Wei
    Sun, Ke
    Wang, Bo
    MODERN PATHOLOGY, 2020, 33 (08) : 1557 - 1562
  • [5] Clinicopathologic Features of Breast Cancers with HER2/CEP17 Ratio &lt;2, HER2 Copy Number ≥4 and &lt;6 Signals/Cell
    Xu, Jin
    Brogi, Edi
    Ventura, Katia
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    MODERN PATHOLOGY, 2019, 32
  • [6] Clinicopathologic Features of Breast Cancers with HER2/CEP17 Ratio &lt;2, HER2 Copy Number ≥4 and &lt;6 Signals/Cell
    Xu, Jin
    Brogi, Edi
    Ventura, Katia
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    LABORATORY INVESTIGATION, 2019, 99
  • [7] HER2/neu-Amplified Breast Cancers with HER2/CEP17 ratio ≥ 2.0 but with an Average HER2 Copy Number &lt;4.0 Signals/Cell: An Assessment of Frequency, Immunohistochemical Correlation, and Clinicopathologic Features
    Zare, Somaye
    Lin, Leo
    Alghamdi, Abrar G.
    Roma, Andres
    Dell'Aquila, Marie
    Hasteh, Farnaz
    Fadare, Oluwole
    MODERN PATHOLOGY, 2018, 31 : 117 - 117
  • [8] HER2/neu-Amplified Breast Cancers with HER2/CEP17 ratio ≥ 2.0 but with an Average HER2 Copy Number &lt;4.0 Signals/Cell: An Assessment of Frequency, Immunohistochemical Correlation, and Clinicopathologic Features
    Zare, Somaye
    Lin, Leo
    Alghamdi, Abrar G.
    Roma, Andres
    Dell'Aquila, Marie
    Hasteh, Farnaz
    Fadare, Oluwole
    LABORATORY INVESTIGATION, 2018, 98 : 117 - 117
  • [9] HER2 positive (HER2/CEP17 ratio≥2.0) invasive mammary carcinomas with average &lt;4.0 HER2 and &lt;2.0 CEP17 signals/cell: Clinicopathologic features, correlation with HER2 immunohistochemistry and response to neoadjuvant chemotherapy
    Livasy, Chad A.
    Limentani, Kimberly
    Calhoun, Benjamin C.
    Limentani, Steven
    CANCER RESEARCH, 2015, 75
  • [10] Breast cancers with a HER2/CEP17 ratio of 2.0 or greater and an average HER2 copy number of less than 4.0 per cell: frequency, immunohistochemical correlation, and clinicopathological features
    Zare, Somaye Y.
    Lin, Leo
    Alghamdi, Abrar G.
    Daehne, Svenja
    Roma, Andres A.
    Hasteh, Farnaz
    Dell'Aquila, Marie
    Fadare, Oluwole
    HUMAN PATHOLOGY, 2019, 83 : 7 - 13
12345